Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 1

Status

Unknown 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4Genitourinary 3Head & Neck 1

Conditions

Breast Neoplasms 4Muscle Weakness 2Motor Activity 2Muscular Atrophy 1

Interventions

Trastuzumab 696Paclitaxel 679Cyclophosphamide 634Docetaxel 554Capecitabine 468Letrozole 407Carboplatin 393Fulvestrant 379Doxorubicin 330Tamoxifen 288pembrolizumab 272Anastrozole 252Epirubicin 249exemestane 238pertuzumab 229Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 118

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Creatine × Breast × Clear all
NCT07372144 2026-01-28

IARA

D'Or Institute for Research and Education

Phase 3 Not yet recruiting
227 enrolled
Breast

Breast Neoplasms

NCT06395506 2025-12-24

THRIVE

The University of Texas Medical Branch, Galveston

Phase NA Recruiting
60 enrolled
Breast

Breast Neoplasms, Motor Activity, Muscle Weakness

NCT05878106 2024-05-09

CaRTiC

University of Deusto

Phase NA Unknown
120 enrolled
Breast

Breast Neoplasms

NCT04207359 2023-07-25

Effects of Creatine Supplementation in Breast Cancer Survivors

The University of Texas Health Science Center at San Antonio

Phase NA Completed
20 enrolled
Breast

Breast Neoplasms, Motor Activity, Muscular Atrophy, Muscle Weakness

Data powered by HemOnc (CC BY 4.0) Colophon âš¡